
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat... Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.383 | -3.56943150047 | 10.73 | 10.7999 | 10.3 | 40579 | 10.5022677 | CS |
4 | -0.073 | -0.700575815739 | 10.42 | 11.45 | 10.07 | 28703 | 10.61694637 | CS |
12 | 2.027 | 24.3629807692 | 8.32 | 11.45 | 7.26 | 46703 | 9.2920309 | CS |
26 | 2.067 | 24.9637681159 | 8.28 | 11.45 | 7.26 | 55396 | 9.24179847 | CS |
52 | -4.543 | -30.5104096709 | 14.89 | 20 | 6.76 | 45571 | 10.14344625 | CS |
156 | -10.103 | -49.4034229829 | 20.45 | 20.66 | 4 | 25556 | 9.06471237 | CS |
260 | -19.673 | -65.5329780147 | 30.02 | 37 | 4 | 22963 | 10.77234167 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales